000 01377 a2200385 4500
005 20250513045000.0
264 0 _c19950221
008 199502s 0 0 eng d
022 _a0004-5632
024 7 _a10.1177/000456329403100503
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHolt, D W
245 0 0 _aMethodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force.
_h[electronic resource]
260 _bAnnals of clinical biochemistry
_cSep 1994
300 _a420-46 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAmino Acid Sequence
650 0 4 _aAutoimmune Diseases
_xdrug therapy
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCyclosporine
_xadverse effects
650 0 4 _aDrug Monitoring
650 0 4 _aHumans
650 0 4 _aImmunoassay
650 0 4 _aMolecular Sequence Data
650 0 4 _aOrgan Transplantation
_xadverse effects
650 0 4 _aQuality Control
650 0 4 _aUnited Kingdom
700 1 _aJohnston, A
700 1 _aRoberts, N B
700 1 _aTredger, J M
700 1 _aTrull, A K
773 0 _tAnnals of clinical biochemistry
_gvol. 31 ( Pt 5)
_gp. 420-46
856 4 0 _uhttps://doi.org/10.1177/000456329403100503
_zAvailable from publisher's website
999 _c7831911
_d7831911